Clinical Trial

Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial

Name: Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial — clinical trial record (NCT07651956)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Patients presenting for a scheduled cesarean delivery who require a neuraxial anesthetic will be randomized to receive intravenous remimazolam or dexmedetomidine for procedural sedation during the placement of their spinal or epidural anesthesia.

Trial Details

NCT Number	NCT07651956
Lead Sponsor	Icahn School of Medicine at Mount Sinai
Conditions	Pregnant People, Anxiety
Enrollment	150 participants
Start Date	2026-09
Primary Completion	2028-05 (estimated)
Study Completion	2028-05 (estimated)
Updated on ClinicalTrials.gov	2026-07-28